| Code | CSB-MP009514MO1 |
| Abbreviation | Recombinant Mouse Glp1r protein, partial (Active) |
| MSDS | |
| Size | $256 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
GLP-1R mediates incretin signaling central to glucose homeostasis and is a validated target for metabolic disease therapeutics, yet studying its extracellular domain in isolation requires a protein that preserves native epitope presentation. This mammalian-expressed fragment spanning residues 22–145 captures the N-terminal ligand-binding domain and demonstrates functional binding to an anti-GLP1R recombinant antibody with an EC50 of 141.7–172.4 ng/mL in ELISA, confirming conformational integrity suitable for antibody epitope mapping, competitive inhibition screening, and therapeutic antibody validation studies. The low endotoxin level (< 1.0 EU/μg) and > 90% purity meet the quality thresholds commonly required for surface plasmon resonance and biolayer interferometry experiments characterizing receptor-ligand affinity or screening small-molecule modulators. Researchers developing GLP-1R-targeted biologics or investigating incretin receptor pharmacology can use this protein as a positive control in binding assays or as an immobilized ligand for drug discovery campaigns.
There are currently no reviews for this product.